Showing results (331-340 of 1,338) with videos related to
Sort By:
Pageof 134
Urology|January 1, 1994
Retroperitoneal tumor eleven years after initial treatment of testicular cancerH Miyamoto, M Moriyama, S Fukushima, et al.Cancer Research|August 1, 1988
Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in LipiodolT Kawaguchi, S Fukushima, Y Hayashi, et al.Carcinogenesis|July 11, 1998
Clonal analysis of urothelial carcinomas in C3H/HeNBALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamineS Yamamoto, M Tatematsu, M Yamamoto, et al.The Journal of Urology|November 1, 1982
Postoperative prophylactic use of progesterone in renal cell carcinomaY Satomi, S Takai, I Kondo, et al.Cancer Research|February 1, 1976
Carcinogenic activity of quinoline on rat liverK Hirao, Y Shinohara, H Tsuda, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humansK Matsubara, S Fukushima, A Akane, et al.Cancer Letters|June 14, 1991
Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administrationM Okumura, T Shirai, M Asamoto, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 1991
[Studies on the anticomplementary activity of Jozann. Anticomplementary activity of steroid derivatives]T Ebihara, T Kawai, M Kuroyanagi, et al.Urological Research|January 1, 1989
Involucrin expression in urinary bladder carcinomaM Asamoto, S Fukushima, H Horike, et al.Japanese Journal of Cancer Research : Gann|November 1, 1986
Changes in the urine and scanning electron microscopically observed appearance of the rat bladder following treatment with tumor promotersS Fukushima, M Shibata, Y Kurata, et al.Pageof 134